Real-world Experience in Managing Atrial Fibrillation in Patients with Renal Impairment; Rivaroxaban versus Warfarin.

Monirah Abdulrahman Albabtain, Zaid Dakheel Alanazi, Nawaf Hamoud Al-Mutairi,Ola Alyafi,Raneem Albanyan,Amr A Arafat

Heart views : the official journal of the Gulf Heart Association(2023)

Cited 0|Views0
No score
Abstract
The safety of warfarin could be better than rivaroxaban in patients with CKD with fewer bleeding complications but similar stroke rates. Further studies on rivaroxaban dosing in patients on dialysis are required.
More
Translated text
Key words
renal impairment,rivaroxaban,vitamin k-dependent anticoagulation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined